A prospective combination of phase II and phase III in drug development (Q478229)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A prospective combination of phase II and phase III in drug development |
scientific article; zbMATH DE number 6376448
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A prospective combination of phase II and phase III in drug development |
scientific article; zbMATH DE number 6376448 |
Statements
A prospective combination of phase II and phase III in drug development (English)
0 references
3 December 2014
0 references
adaptive designs
0 references
conditional power
0 references
drug development
0 references
likelihood-based inference
0 references
skew-normal distribution
0 references
0.768248975276947
0 references
0.7573462128639221
0 references
0.755310595035553
0 references
0.7447075843811035
0 references
